Avricore Health (TSE:AVCR) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Avricore Health Inc. has reported significant mid-year financial growth for 2024, with a 84% increase in revenue and a net profit of $222,559. The company attributes its success to strong partnerships, a dedicated team, and a mission focused on improving access to healthcare. With consecutive profitable quarters and a solid increase in working capital, Avricore is showing potential for further growth in the healthcare sector.
For further insights into TSE:AVCR stock, check out TipRanks’ Stock Analysis page.
